111 related articles for article (PubMed ID: 6826249)
1. Clinical significance of circulating immune complexes in patients with metastatic breast cancer.
Krieger G; Kehl A; Wander HE; Salo AM; Rauschecker HF; Nagel GA
Int J Cancer; 1983 Feb; 31(2):207-11. PubMed ID: 6826249
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of circulating immune complexes in patients with metastatic breast cancer].
Krieger G; Kehl A; Bause I; Kneba M; Nagel GA
Klin Wochenschr; 1982 Dec; 60(23):1465-72. PubMed ID: 7154620
[TBL] [Abstract][Full Text] [Related]
3. Circulating immune complexes (CIC), carcinoembryonic antigen (CEA) and CIC containing CEA as markers for colorectal cancer.
Chester KA; Begent RH
Clin Exp Immunol; 1984 Dec; 58(3):685-93. PubMed ID: 6509799
[TBL] [Abstract][Full Text] [Related]
4. [Circulating immune complexes in breast cancer].
Abecassis J; Petit JC; Eber M; Klein T; Rodier D; Janser JC; Methlin G
Bull Cancer; 1985; 72(1):42-7. PubMed ID: 3872691
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of circulating immune complexes in patients with breast cancer.
Bukh A; Aguado MT; Krarup N; Poulsen HS; Nordentoft AM; Møller NP
Int J Cancer; 1988 Mar; 41(3):364-70. PubMed ID: 3257943
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of circulating immune complexes in a long-term follow-up of breast cancer patients.
Iaffaioli RV; Bianchin A; Ruggiero G; Pirozzi G; Ungaro A; Totaro G; Gallo C; De Placido S; Pagliarulo C; Bianco AR
Oncology; 1988; 45(5):337-43. PubMed ID: 3412739
[TBL] [Abstract][Full Text] [Related]
7. Circulating immune complexes (CIC) as tumor marker in the follow-up of breast cancer.
Neri B; Comparini T; Ciatto S; Cataliotti L; Distante V; Bartalucci S
Cancer Detect Prev; 1985; 8(1-2):53-6. PubMed ID: 4064052
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal follow-up circulating immune complexes of the serum in patients with breast cancer.
Nekulová M; Tomanová J; Lang BA
Neoplasma; 1982; 29(5):573-7. PubMed ID: 7177247
[TBL] [Abstract][Full Text] [Related]
9. Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumours.
von Mensdorff-Pouilly S; Gourevitch MM; Kenemans P; Verstraeten AA; Litvinov SV; van Kamp GJ; Meijer S; Vermorken J; Hilgers J
Eur J Cancer; 1996 Jul; 32A(8):1325-31. PubMed ID: 8869094
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility and monitoring of breast cancer by circulating immune complexes.
Dass TK; Aziz M; Rattan A; Tyagi SP
Indian J Pathol Microbiol; 1992 Oct; 35(4):298-307. PubMed ID: 1344219
[TBL] [Abstract][Full Text] [Related]
11. Circulating immune complexes in patients following clinically curative resection of colorectal cancer.
Steele G; Sonis S; Stelos P; Rittgers R; Zamcheck N; Finn D; Maltz J; Mayer R; Lokich J; Wilson RE
Surgery; 1978 Jun; 83(6):648-54. PubMed ID: 205963
[TBL] [Abstract][Full Text] [Related]
12. Immune complexes of IgG1 and IgG3 subclasses in human breast cancer sera detected by monoclonal antibodies in an indirect immunoenzymatic assay.
Manzo C; Bianchin A; Pirozzi G; Totaro G
Oncology; 1983; 40(6):395-9. PubMed ID: 6358985
[TBL] [Abstract][Full Text] [Related]
13. Serial circulating immune complex values and development of metastatic disease in breast cancer and malignant melanoma patients.
Ronai Z; Shaham J; Stein J; Sulitzeanu D
Cancer Immunol Immunother; 1986; 22(1):72-5. PubMed ID: 3518930
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of circulating immune complexes in cancer patients.
Dass TK; Aziz M; Rattan A
Jpn J Cancer Res; 1991 Nov; 82(11):1284-91. PubMed ID: 1752784
[TBL] [Abstract][Full Text] [Related]
15. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer humoral immune response: involvement of Lewis y through the detection of circulating immune complexes and association with Mucin 1 (MUC1).
Isla Larrain M; Demichelis S; Crespo M; Lacunza E; Barbera A; Cretón A; Terrier F; Segal-Eiras A; Croce MV
J Exp Clin Cancer Res; 2009 Aug; 28(1):121. PubMed ID: 19715603
[TBL] [Abstract][Full Text] [Related]
17. Uses and limitations in the demonstration of specific circulating immune complexes in patients with amoebiasis.
Vinayak VK; Shandil RK; Bansal V; Singh K; Bhasin DK; Kaur U
J Med Microbiol; 1990 Jun; 32(2):87-91. PubMed ID: 2355392
[TBL] [Abstract][Full Text] [Related]
18. Humoral immunity and composition of immune complexes in patients with rheumatoid arthritis, with special reference to IgE-containing immune complexes.
De Clerck LS; Struyf NJ; Bridts CH; Francx L; Van Offel JF; Empsten FA; Westedt ML; Breedveld FC; Cats A; Stevens WJ
Clin Exp Rheumatol; 1989; 7(5):485-92. PubMed ID: 2591122
[TBL] [Abstract][Full Text] [Related]
19. Circulating immune complexes in patients with rheumatoid arthritis: correlation with disease activity.
Levo Y; Fischel R; Ehrenfeld M
J Rheumatol; 1981; 8(5):851-5. PubMed ID: 7310781
[TBL] [Abstract][Full Text] [Related]
20. A phase II trial of extracorporeal plasma immunoadsorption of patient plasma with PROSORBA columns for treating metastatic breast cancer.
Fennelly DW; Norton L; Sznol M; Hakes TB
Cancer; 1995 Apr; 75(8):2099-102. PubMed ID: 7697600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
